FeaturesSignalPricingFounders
Log inGet started free
CI

California Institute for Regenerative Medicine

Micro VCActive

The California Institute for Regenerative Medicine (The Institute or CIRM) was established in early 2005 following the passage of

San Francisco, United StatesFounded 2016cirm.ca.gov
13
Investments
8
Exits
AUM
61.5%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for California Institute for Regenerative Medicine.

Get started free

Investment Thesis & Strategy

CIRM invests in various stages of biotech, life science, and healthcare companies, with a focus on regenerative medicine and stem cell research. They seek to accelerate therapies and cures for diseases through funding and support.

Investment Activity

Deals per year over the last 14 years

1
2010
0
2011
0
2012
0
2013
1
2014
0
2015
3
2016
0
2017
4
2018
0
2019
0
2020
1
2021
1
2022
1
2023

Portfolio Companies

Selected investments from their portfolio of 13 companies

O
Obsidio
Biotech · Series A, 2023
Active
C
CureSource
Biotech · Growth, 2022
Active
C
Century Therapeutics
Biotech · Growth, 2021
Active
C
City of Hope
Healthcare · Growth, 2018
Active
L
Lineage Cell Therapeutics
Biotech · Growth, 2018
Active
L
Lyell Immunopharma
Biotech · Growth, 2018
Active
C
CIRM Alpha Clinics
Healthcare · Growth, 2018
Active
N
Neuronyx
Biotech · Growth, 2016
Active
C
Capricor Therapeutics
Biotech · Growth, 2016
Active
A
Allogene Therapeutics
Biotech · Growth, 2016
Active
V
ViaCyte
Biotech · Growth, 2014
Active
A
Athersys
Biotech · Growth, 2010
Active

Frequently Asked Questions

California Institute for Regenerative Medicine focuses on Seed, Series A stage investments.

Related Investors